FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1842241528> ?p ?o ?g. }

• W1842241528 endingPage "817" @default.
• W1842241528 startingPage "799" @default.
• W1842241528 abstract "The present study sought to determine the anti-tumor effects of OXA-11, a potent, novel small-molecule amino pyrimidine inhibitor (1.2 pM biochemical IC(50)) of focal adhesion kinase (FAK). In studies of cancer cell lines, OXA-11 inhibited FAK phosphorylation at phospho-tyrosine 397 with a mechanistic IC(50) of 1 nM in TOV21G tumor cells, which translated into functional suppression of proliferation in 3-dimensional culture with an EC(50) of 9 nM. Studies of OXA-11 activity in TOV21G tumor-cell xenografts in mice revealed a pharmacodynamic EC(50) of 1.8 nM, indicative of mechanistic inhibition of pFAK [Y397] in these tumors. OXA-11 inhibited TOV21G tumor growth in a dose-dependent manner and also potentiated effects of cisplatin on tumor cell proliferation and apoptosis in vitro and on tumor growth in mice. Studies of pancreatic neuroendocrine tumors in RIP-Tag2 transgenic mice revealed OXA-11 suppression of pFAK [Y397] and pFAK [Y861] in tumors and liver. OXA-11 given daily from age 14 to 17 weeks reduced tumor vascularity, invasion, and when given together with the anti-VEGFR-2 antibody DC101 reduced the incidence, abundance, and size of liver metastases. Liver micrometastases were found in 100 % of mice treated with vehicle, 84 % of mice treated with OXA-11, and 79 % of mice treated with DC101 (19-24 mice per group). In contrast, liver micrometastases were found in only 52 % of 21 mice treated with OXA-11 plus DC101, and those present were significantly smaller and less numerous. Together, these findings indicate that OXA-11 is a potent and selective inhibitor of FAK phosphorylation in vitro and in vivo. OXA-11 slows tumor growth, potentiates the anti-tumor actions of cisplatin and--when combined with VEGFR-2 blockade--reduces metastasis of pancreatic neuroendocrine tumors in RIP-Tag2 mice." @default.
• W1842241528 created "2016-06-24" @default.
• W1842241528 creator A5003462092 @default.
• W1842241528 creator A5013728459 @default.
• W1842241528 creator A5031912982 @default.
• W1842241528 creator A5064706698 @default.
• W1842241528 creator A5075114107 @default.
• W1842241528 creator A5091671499 @default.
• W1842241528 date "2015-10-07" @default.
• W1842241528 modified "2023-10-15" @default.
• W1842241528 title "Anti-metastatic action of FAK inhibitor OXA-11 in combination with VEGFR-2 signaling blockade in pancreatic neuroendocrine tumors" @default.
• W1842241528 cites W1430273632 @default.
• W1842241528 cites W1516077090 @default.
• W1842241528 cites W1524238275 @default.
• W1842241528 cites W1604140953 @default.
• W1842241528 cites W1904209158 @default.
• W1842241528 cites W1966296292 @default.
• W1842241528 cites W1966969455 @default.
• W1842241528 cites W1967197989 @default.
• W1842241528 cites W1967600348 @default.
• W1842241528 cites W1972634051 @default.
• W1842241528 cites W1977999028 @default.
• W1842241528 cites W1981366726 @default.
• W1842241528 cites W2004976275 @default.
• W1842241528 cites W2012047032 @default.
• W1842241528 cites W2013692456 @default.
• W1842241528 cites W2021705436 @default.
• W1842241528 cites W2024104654 @default.
• W1842241528 cites W2028667039 @default.
• W1842241528 cites W2030234664 @default.
• W1842241528 cites W2031501894 @default.
• W1842241528 cites W2032843265 @default.
• W1842241528 cites W2033711687 @default.
• W1842241528 cites W2035757068 @default.
• W1842241528 cites W2038974287 @default.
• W1842241528 cites W2039013742 @default.
• W1842241528 cites W2039097790 @default.
• W1842241528 cites W2042540245 @default.
• W1842241528 cites W2043686550 @default.
• W1842241528 cites W2044423100 @default.
• W1842241528 cites W2044895919 @default.
• W1842241528 cites W2050278370 @default.
• W1842241528 cites W2054477288 @default.
• W1842241528 cites W2058843732 @default.
• W1842241528 cites W2064335213 @default.
• W1842241528 cites W2065088072 @default.
• W1842241528 cites W2073212944 @default.
• W1842241528 cites W2087767745 @default.
• W1842241528 cites W2088179569 @default.
• W1842241528 cites W2088616287 @default.
• W1842241528 cites W2089723533 @default.
• W1842241528 cites W2090512174 @default.
• W1842241528 cites W2101025132 @default.
• W1842241528 cites W2104924788 @default.
• W1842241528 cites W2105766219 @default.
• W1842241528 cites W2113082600 @default.
• W1842241528 cites W2114462664 @default.
• W1842241528 cites W2118105104 @default.
• W1842241528 cites W2121220704 @default.
• W1842241528 cites W2121290668 @default.
• W1842241528 cites W2124373629 @default.
• W1842241528 cites W2135604793 @default.
• W1842241528 cites W2140088548 @default.
• W1842241528 cites W2142258398 @default.
• W1842241528 cites W2142682878 @default.
• W1842241528 cites W2146706439 @default.
• W1842241528 cites W2152869165 @default.
• W1842241528 cites W2162571831 @default.
• W1842241528 cites W2164279183 @default.
• W1842241528 cites W2165905376 @default.
• W1842241528 cites W2166424759 @default.
• W1842241528 cites W2170633837 @default.
• W1842241528 cites W2171179595 @default.
• W1842241528 cites W2205207487 @default.
• W1842241528 cites W2310034942 @default.
• W1842241528 cites W3023318419 @default.
• W1842241528 cites W4254123044 @default.
• W1842241528 doi "https://doi.org/10.1007/s10585-015-9752-z" @default.
• W1842241528 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4651821" @default.
• W1842241528 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26445848" @default.
• W1842241528 hasPublicationYear "2015" @default.
• W1842241528 type Work @default.
• W1842241528 sameAs 1842241528 @default.
• W1842241528 citedByCount "16" @default.
• W1842241528 countsByYear W18422415282016 @default.
• W1842241528 countsByYear W18422415282017 @default.
• W1842241528 countsByYear W18422415282018 @default.
• W1842241528 countsByYear W18422415282019 @default.
• W1842241528 countsByYear W18422415282021 @default.
• W1842241528 countsByYear W18422415282022 @default.
• W1842241528 countsByYear W18422415282023 @default.
• W1842241528 crossrefType "journal-article" @default.
• W1842241528 hasAuthorship W1842241528A5003462092 @default.
• W1842241528 hasAuthorship W1842241528A5013728459 @default.
• W1842241528 hasAuthorship W1842241528A5031912982 @default.
• W1842241528 hasAuthorship W1842241528A5064706698 @default.
• W1842241528 hasAuthorship W1842241528A5075114107 @default.
• W1842241528 hasAuthorship W1842241528A5091671499 @default.

• next